Profounda

Profounda is a US-based, private specialty pharma company with a dual focus on proprietary drug development and contract manufacturing. Its commercial strategy targets niche therapeutic areas, primarily infectious and rare diseases, with an initial marketed product line for nasal care and a key branded drug for a parasitic infection. The company leverages its internal development expertise and manufacturing capabilities to generate revenue while building a pipeline of specialty pharmaceutical products.

Integrated model combining niche specialty pharmaceutical development with contract manufacturing capabilities for OTC and cosmetic products.

In contract manufacturing, Profounda competes with numerous large and small CMOs. For its proprietary drugs like Impavido, competition is limited within its specific niche indications but subject to broader antimicrobial development and generic pricing pressures. Its Rhinase line faces competition from many OTC nasal care brands.